ProActive Capital Group If you take a look at the chart for TherapeuticsMD, you’ll notice that this stock has been uptrending strong over the last three months, with shares soaring higher from its low of $2.03 to its recent high of $5.27 a share. During that uptrend, shares of TXMD have been making mostly higher lows and higher highs, which is bullish technical price action. … Read more
ForceField Energy Inc. (“ForceField”) (FNRG), an international manufacturer, seller and distributor of energy products and solutions, announced today it was awarded a contract with the Comptroller General’s Office of the Republic of Costa Rica, which oversees the use of public funds to improve the management of public finances, to supply and install its SL3 LED street lights in the government agency’s parking facility. … Read more
ProActive Capital Group Hysterectomy and oophorectomy (the removal of ovaries) are performed to treat various diseases in women, includingcancer. These procedures are accompanied not only by a decline in estrogen but also testosterone levels in the blood. Many women who have undergone surgical removal of their uterus and/or ovaries can develop symptoms of sexual dysfunction, fatigue, low mood and decreased muscle mass. … Read more
NXT-ID, Inc., (OTCQB: NXTD) a biometrics company focused on the growing mobile commerce market, today announced features of its next generation wallet, The Wocket™, scheduled for launch for the first quarter of 2014.
The Wocket is designed to replace all the cards in your wallet with a single, secure smart card. The Wocket works anywhere that credit cards are accepted and can only be
AtheroNova Inc. (AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and … Read more
Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) (SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced it will be providing an update on its immune checkpoint program targeting the CD47 protein at the 55th Annual Meeting of the American Society of Hematology, which will be held December 7-10, 2013 in New Orleans, LA. Details of the poster presentation, entitled “Blockade of … Read more
Tauriga Sciences Inc. (TAUG) or (“Tauriga” or “the Company”), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nanorobotics space, has today highlighted some recent positive media coverage regarding its pending acquisition of Pilus Energy LLC (“Pilus Energy”). The list of articles compiled below, which includes the corresponding links, is for … Read more
Clearwayz patented formula supports anti-inflammatory processes in the sinuses and respiratory system and provides the nutrients that support a healthy immune response to common allergens.
Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced a new application for their dietary supplement Clearwayz. The product which currently supports healthy sinus and immune function has also shown the ability in multiple open label trials to support healthy respiratory … Read more
Soligenix, Inc. (SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator (IDR), as a treatment for oral … Read more
TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company (“TherapeuticsMD” or the “Company”), announced today the appointment of Joel S. Krasnow, M.D., M.B.A., a leading board-certified OB/GYN and reproductive endocrinologist with broad biotech and pharmaceutical experience, as the Company’s Chief Scientific Officer and head of its regulatory department.
Dr. Krasnow’s career spans 15 years in the pharmaceutical industry, including several global product registrations in women’s … Read more